Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease rela

Updated on: April 28,2024 0

Investigational personalized vaccine provides clinical benefit for some patients with resected head and neck cancers

byAmerican Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainTG4050, a personalized neoantigen vaccine, induced tumor-specific immune responses and led to low rates of disease rela

Updated on:April 28,2024 0

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on: April 06,2024 0

Prostate cancer is the second-leading cancer among men. Here's what to know about it

by Erin Kayata,Northeastern UniversityCredit: Pixabay/CC0 Public DomainCancer rates, especially among young people, are on the rise. There's expected to be 2 million new cancer diagnoses in

Updated on:April 06,2024 0

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Updated on: March 20,2024 19

'Dual-target' cell therapy appears to shrink brain tumors, research finds

by Perelman School of Medicine at the University of PennsylvaniaCredit: Anna Shvets from PexelsTargeting two brain tumor-associated proteins—rather than one—with CAR T cell therapy shows promise

Updated on:March 20,2024 19

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on: January 28,2024 13

A new combination therapy regimen shows promising results for prostate cancer

by Huntsman Cancer InstituteCredit: CC0 Public DomainTALAPRO-2, a study led by Neeraj Agarwal, MD, demonstrated that using TALZENNA, in combination with XTANDI, may reduce the risk of disease progress

Updated on:January 28,2024 13

Researcher pioneers method of detecting early-stage cancer: Cheaper, faster, less invasive and accurate

by Dave Raney,University of CincinnatiJiajie Diao and his collaboratorare working with UC’s Technology Transfer team to commercialize their new method for early cancer diagnosis. Credit: C

Updated on: January 30,2024 17

Researcher pioneers method of detecting early-stage cancer: Cheaper, faster, less invasive and accurate

by Dave Raney,University of CincinnatiJiajie Diao and his collaboratorare working with UC’s Technology Transfer team to commercialize their new method for early cancer diagnosis. Credit: C

Updated on:January 30,2024 17

Research reveals potential targets for therapeutic development for glioblastoma

by Amy Richardson,University of Alabama at BirminghamGraphical abstract. Credit:JCI Insight(2022). DOI: 10.1172/jci.insight.148717The University of Alabama at Birmingham Marnix E. He

Updated on: February 03,2024 18

Research reveals potential targets for therapeutic development for glioblastoma

by Amy Richardson,University of Alabama at BirminghamGraphical abstract. Credit:JCI Insight(2022). DOI: 10.1172/jci.insight.148717The University of Alabama at Birmingham Marnix E. He

Updated on:February 03,2024 18

The role of 'extra' DNA in cancer evolution and therapy resistance

by Sarah Laskowski,Henry Ford Health SystemCredit: Henry Ford Health SystemGlioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is po

Updated on: March 13,2024 15

The role of 'extra' DNA in cancer evolution and therapy resistance

by Sarah Laskowski,Henry Ford Health SystemCredit: Henry Ford Health SystemGlioblastoma (GBM) is the most common and aggressive form of brain cancer. Response to standard-of-care treatment is po

Updated on:March 13,2024 15

New research explores options for motherhood in lung cancer patients

byCU Anschutz Medical CampusOverall survival of women 18-44 with advanced lung cancer by oncogene driver (N=48). Note: Data truncated at 10 years. One woman with ALK rearranged lung cancer died

Updated on: January 13,2024 15

New research explores options for motherhood in lung cancer patients

byCU Anschutz Medical CampusOverall survival of women 18-44 with advanced lung cancer by oncogene driver (N=48). Note: Data truncated at 10 years. One woman with ALK rearranged lung cancer died

Updated on:January 13,2024 15

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on: February 20,2024 17

Toward a personalized approach to the study and treatment of bone cancers

by Lund UniversityPrimary acute myeloid leukemia cells preferentially home and engraft in MSOD-B hOss.a, Experimental scheme of AML patient sample transplantation. b, Representative histological

Updated on:February 20,2024 17

Extending chemo slashes risk of aggressive childhood leukemia coming back

by Princess Máxima Center for Pediatric OncologyCredit: CC0 Public DomainMany children with acute lymphoblastic leukemia (ALL) have a good outcome of their disease. After two years of chemotherapy tre

Updated on: January 16,2024 17

Extending chemo slashes risk of aggressive childhood leukemia coming back

by Princess Máxima Center for Pediatric OncologyCredit: CC0 Public DomainMany children with acute lymphoblastic leukemia (ALL) have a good outcome of their disease. After two years of chemotherapy tre

Updated on:January 16,2024 17

Targeted treatment could prevent spread of pancreatic cancer, heart damage

by Katie Pence,University of Cincinnati Academic Health CenterPancreatic cancer cells, under a microscope. Credit: University of CincinnatiResearchers at the University of Cincinnati (UC) Colleg

Updated on: May 07,2024 14

Targeted treatment could prevent spread of pancreatic cancer, heart damage

by Katie Pence,University of Cincinnati Academic Health CenterPancreatic cancer cells, under a microscope. Credit: University of CincinnatiResearchers at the University of Cincinnati (UC) Colleg

Updated on:May 07,2024 14

Clues found regarding tumor suppressor gene's breast cancer activity

byJohns Hopkins University School of MedicineCredit: Saraswati Sukumar and Priya PaiResearchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress fo

Updated on: January 21,2024 19

Clues found regarding tumor suppressor gene's breast cancer activity

byJohns Hopkins University School of MedicineCredit: Saraswati Sukumar and Priya PaiResearchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress fo

Updated on:January 21,2024 19